Deals
Deal activity by volume related to robotics decreased by 11% year-on-year in 2022 in the pharmaceutical industry
Credit: Bert van Dijk/Getty images.
Powered by
Analysis of the key themes driving deal activity reveals that robotics accounted for 148 pharmaceutical deals between 2018 and 2022, worth a total value of $4,893m, according to GlobalData’s Deals database covering mergers and acquisitions, private equity, venture financing, equity offerings and partnerships.
The $100m acquisition of InstaDeep by Synergie was the largest disclosed deal in 2022, while the $255m venture financing by InSilico Medicine was the largest disclosed deal in 2021.
In volume terms, robotics related deal activity decreased by 11% year-on-year in 2022 and decreased by 10% year-on-year in 2021.
Deal activity related to robotics in the global pharmaceutical industry in the last five years
Top deals related to robotics in the pharmaceutical industry in the last five years
Deal volume by deal type for robotics related deals in the pharmaceutical industry in the last five years
Partnerships accounted for the highest number of deals in the last five years, with 66 deals, followed by venture financing (52 deals), and equity offerings (13 deals).
Top financial advisors for robotics related deals by value in the pharmaceutical industry in the last five years
The top financial advisors supporting deals related to robotics in the pharmaceutical industry in the last five years in terms of value were Credit Suisse Group, HC Wainwright, Rothschild, Cowen and Company, and H.C. Wainwright.
Top legal advisors for robotics related deals by value in the pharmaceutical industry in the last five years
The top legal advisors supporting deals related to robotics in the pharmaceutical industry in the last five years in terms of value were Cooley, DLA Piper, Freshfields Bruckhaus Deringer, Gleiss Lutz Hootz Hirsch, and Ashurst.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Deals database provides comprehensive coverage across industries tracking market activity of global mergers & acquisitions, including asset acquisitions/divestments; private equity deals (PE); venture finance deals (VC); equity offerings, including IPOs, follow-on offerings, and private placements; debt offerings, including private placements, ESG bonds and loans; partnerships; and licensing agreements.
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumored deals.
